Astrazeneca (AZNCF) Short-Term Debt issuances (2019 - 2025)
Historic Short-Term Debt issuances for Astrazeneca (AZNCF) over the last 7 years, with Q4 2025 value amounting to -$29.6 billion.
- Astrazeneca's Short-Term Debt issuances rose 222.15% to -$29.6 billion in Q4 2025 from the same period last year, while for Dec 2025 it was -$29.6 billion, marking a year-over-year increase of 222.15%. This contributed to the annual value of -$29.6 billion for FY2025, which is 222.15% up from last year.
- Per Astrazeneca's latest filing, its Short-Term Debt issuances stood at -$29.6 billion for Q4 2025, which was up 222.15% from -$32.6 billion recorded in Q3 2025.
- Astrazeneca's Short-Term Debt issuances' 5-year high stood at -$399.0 million during Q1 2021, with a 5-year trough of -$34.6 billion in Q1 2024.
- In the last 5 years, Astrazeneca's Short-Term Debt issuances had a median value of -$30.7 billion in 2022 and averaged -$28.3 billion.
- Per our database at Business Quant, Astrazeneca's Short-Term Debt issuances soared by 848.62% in 2021 and then crashed by 769423.56% in 2022.
- Quarter analysis of 5 years shows Astrazeneca's Short-Term Debt issuances stood at -$399.0 million in 2021, then plummeted by 7226.32% to -$29.2 billion in 2022, then grew by 2.09% to -$28.6 billion in 2023, then dropped by 5.85% to -$30.3 billion in 2024, then increased by 2.22% to -$29.6 billion in 2025.
- Its Short-Term Debt issuances stands at -$29.6 billion for Q4 2025, versus -$32.6 billion for Q3 2025 and -$31.6 billion for Q1 2025.